4MGS Test Predicts IPF Patient Mortality, Hospitalization, Study Says
Gait speed, measured by the four meter gait speed (4MGS) test, is an independent predictor of all-cause mortality and hospitalization in patients with ... Read more
Updates
-
-
Self-compassion Helps Us Deal with Pulmonary Fibrosis
Pulmonary fibrosis patients need all the compassion we can get. It turns out that the most important person to give us compassion is … ... Read more -
Nasal Sampling May Be Fast and Noninvasive Way to Identify and Manage IPF, Study Suggests
The nasal epithelium of patients with idiopathic pulmonary fibrosis (IPF) shows different levels of gene expression implicated in inflammatory and immune responses than ... Read more -
Veracyte Expands Early Access to Envisia Genomic Classifier Test for IPF Diagnosis
Veracyte recently announced the expansion of an early access program offering the Envisia Genomic Classifier test for the diagnosis of idiopathic pulmonary fibrosis ... Read more -
Esbriet Extends IPF Patient Survival, Real-world Study Reports
Esbriet (pirfenidone) can improve survival rates of idiopathic pulmonary fibrosis (IPF) patients by 30 percent, a real-world retrospective analysis shows. The study, “Pirfenidone improves ... Read more
-
4MGS Test Predicts IPF Patient Mortality, Hospitalization, Study Says
Gait speed, measured by the four meter gait speed (4MGS) test, is an independent ... -
Self-compassion Helps Us Deal with Pulmonary Fibrosis
Pulmonary fibrosis patients need all the compassion we can get. It turns out that ... -
Nasal Sampling May Be Fast and Noninvasive Way to Identify and Manage IPF, Study Suggests
The nasal epithelium of patients with idiopathic pulmonary fibrosis (IPF) shows different levels of ... -
Veracyte Expands Early Access to Envisia Genomic Classifier Test for IPF Diagnosis
Veracyte recently announced the expansion of an early access program offering the Envisia Genomic Classifier ... -
Esbriet Extends IPF Patient Survival, Real-world Study Reports
Esbriet (pirfenidone) can improve survival rates of idiopathic pulmonary fibrosis (IPF) patients by 30 percent, ... -
Tips to Conserve Energy During Holiday Gatherings
With the holiday season upon us, the social gatherings have begun. An unofficial start ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more